EUVIMED · CrossrefZeitschrift
Hepatobiliary Surgery and Nutrition
ISSN 2304-3881 · AME Publishing Company
Neueste Artikel
Advancing the enhanced recovery after surgery paradigm in liver transplantation: evidence-based strategies for a comprehensive care continuum
What is new in the 2025 APASL guidelines for metabolic dysfunction-associated fatty liver disease?
Comprehensive treatment and surgical features of giant hepatic hemangioma with Kasabach-Merritt syndrome in an adult
Radiofrequency ablation for colorectal liver metastases: an evolving alternative or complement to resection?
Laparoscopic versus robotic pancreaticoduodenectomy for distal cholangiocarcinoma after learning curves of surgeons: a multicenter propensity score-matched study
The future of hepatobiliary surgical oncology
Technical performance, surgical workload and patient outcomes of robotic and laparoscopic surgery for pediatric choledochal cyst: a multicenter retrospective cohort and propensity score-matched study
New perspectives in biology-driven treatment of cholangiocarcinoma: from oncological resectability to genetic breakthroughs and AI-powered imaging
The risk of hepatocellular carcinoma recurrence after liver transplantation increases with locoregional therapies in patients initially within Milan criteria
Prognostic factors in gallbladder cancer: a comprehensive systematic review and meta-analysis
Enhanced recovery after liver transplantation—a prospective analysis focusing on quality assessment
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition)
Neoadjuvant immunotherapy for hepatocellular carcinoma: progress and perspectives
2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach
Comparative associations of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease with risk of incident chronic kidney disease: a cohort study
Radiofrequency ablation versus microwave ablation for colorectal liver metastases: long-term results of a retrospective cohort surgical experience
New guidelines for screening, evaluation and management of hepatobiliary disease in cystic fibrosis
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment
A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact
Pathologic assessment of hepatocellular carcinoma in the era of immunotherapy: a narrative review
Physical activity decreases in patients on the liver transplant waiting list and influences postoperative outcome—a prospective cohort study
Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review
The global burden of fatty liver disease: the major impact of China
Primary liver cancer spectrum: current knowledge and the next steps
Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives
Laparoscopic anatomical versus non-anatomical liver resection for hepatocellular carcinoma in the posterosuperior segments: a propensity score matched analysis
Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China
Update on herbal and dietary supplement-induced liver injury: current gaps and future directions
Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies
EUVIMED